High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia
Authors
Keywords
Chronic myeloid leukemia, Mesenchymal stem cells, IL-7, Imatinib
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 104, Issue 3, Pages 358-367
Publisher
Springer Nature
Online
2016-06-06
DOI
10.1007/s12185-016-2028-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
- (2014) X. Li et al. ARCHIVES OF TOXICOLOGY
- Advances in understanding the leukaemia microenvironment
- (2014) Yoko Tabe et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
- (2014) L Schafranek et al. LEUKEMIA
- Decreased frequency, but normal functional integrity of mesenchymal stromal cells derived from untreated and Imatinib-treated chronic myeloid leukemia patients
- (2014) P.K. Estrada-González et al. LEUKEMIA RESEARCH
- Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo
- (2014) K. Beider et al. MOLECULAR CANCER THERAPEUTICS
- New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
- (2014) Saeid Shahrabi et al. TUMOR BIOLOGY
- Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt- -catenin signaling
- (2013) B. Zhang et al. BLOOD
- Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia
- (2013) Concetta Quintarelli et al. LEUKEMIA RESEARCH
- The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
- (2012) J M Houthuijzen et al. BRITISH JOURNAL OF CANCER
- Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
- (2012) Bin Zhang et al. CANCER CELL
- Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: Key role of stromal microenvironment
- (2012) P.F. Seke Etet et al. CELLULAR SIGNALLING
- IL-7 in human health and disease
- (2012) Wangko Lundström et al. SEMINARS IN IMMUNOLOGY
- IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis
- (2012) Florent Carrette et al. SEMINARS IN IMMUNOLOGY
- High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
- (2011) W. Warsch et al. BLOOD
- Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile
- (2011) W. T. Parker et al. BLOOD
- p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells
- (2011) L F Peterson et al. LEUKEMIA
- The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
- (2010) Rajesh R. Nair et al. BIOCHEMICAL PHARMACOLOGY
- Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
- (2010) F. Vianello et al. HAEMATOLOGICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now